| Wed, 2 Sep 2026 | Schmid Timothy | officer: EVP, WW Chair, MedTech | M-Exempt | 22,527 | $3.41M |
| Wed, 2 Sep 2026 | Schmid Timothy | officer: EVP, WW Chair, MedTech | S-Sale | 22,527 | $6.19M |
| Wed, 2 Sep 2026 | Schmid Timothy | officer: EVP, WW Chair, MedTech | S-Sale | 11,070 | $3.04M |
| Wed, 2 Sep 2026 | Schmid Timothy | officer: EVP, WW Chair, MedTech | M-Exempt | 11,070 | $1.46M |
| Mon, 17 Aug 2026 | Taubert Jennifer L | officer: EVP, WWC. Innovative Medicine | S-Sale | 15,000 | $3.95M |
| Mon, 17 Aug 2026 | Taubert Jennifer L | officer: EVP, WWC. Innovative Medicine | M-Exempt | 15,000 | $1.74M |
| Mon, 17 Aug 2026 | Taubert Jennifer L | officer: EVP, WWC. Innovative Medicine | S-Sale | 15,000 | $3.95M |
| Mon, 17 Aug 2026 | Taubert Jennifer L | officer: EVP, WWC. Innovative Medicine | M-Exempt | 15,000 | $1.74M |
| Thu, 13 Aug 2026 | Duato Joaquin | director, officer: CEO and Chairman of the Board | S-Sale | 102,315 | $26.7M |
| Thu, 13 Aug 2026 | Duato Joaquin | director, officer: CEO and Chairman of the Board | M-Exempt | 123,291 | $14.26M |
| Thu, 13 Aug 2026 | Duato Joaquin | director, officer: CEO and Chairman of the Board | S-Sale | 20,976 | $5.5M |
| Thu, 13 Aug 2026 | Duato Joaquin | director, officer: CEO and Chairman of the Board | S-Sale | 20,976 | $5.5M |
| Thu, 13 Aug 2026 | Duato Joaquin | director, officer: CEO and Chairman of the Board | M-Exempt | 123,291 | $14.26M |
| Thu, 13 Aug 2026 | Duato Joaquin | director, officer: CEO and Chairman of the Board | S-Sale | 102,315 | $26.7M |
| Wed, 5 Aug 2026 | Duato Joaquin | director, officer: CEO and Chairman of the Board | S-Sale | 41,957 | $10.83M |
| Thu, 6 Aug 2026 | Forminard Elizabeth | officer: EVP, Chief Legal Officer | M-Exempt | 9,344 | $1.23M |
| Wed, 5 Aug 2026 | Duato Joaquin | director, officer: CEO and Chairman of the Board | S-Sale | 6,523 | $1.69M |
| Wed, 5 Aug 2026 | Duato Joaquin | director, officer: CEO and Chairman of the Board | S-Sale | 6,523 | $1.69M |
| Wed, 5 Aug 2026 | Duato Joaquin | director, officer: CEO and Chairman of the Board | S-Sale | 41,957 | $10.83M |
| Thu, 6 Aug 2026 | Forminard Elizabeth | officer: EVP, Chief Legal Officer | M-Exempt | 9,344 | $1.23M |
| Thu, 6 Aug 2026 | Forminard Elizabeth | officer: EVP, Chief Legal Officer | S-Sale | 9,344 | $2.41M |
| Thu, 6 Aug 2026 | Forminard Elizabeth | officer: EVP, Chief Legal Officer | S-Sale | 6,574 | $1.68M |
| Thu, 6 Aug 2026 | Forminard Elizabeth | officer: EVP, Chief Legal Officer | S-Sale | 9,344 | $2.41M |
| Thu, 6 Aug 2026 | Forminard Elizabeth | officer: EVP, Chief Legal Officer | S-Sale | 6,574 | $1.68M |
| Mon, 20 Jul 2026 | Broadhurst Vanessa | officer: EVP, Global Corp Affairs | S-Sale | 23,054 | $5.79M |
| Mon, 20 Jul 2026 | Broadhurst Vanessa | officer: EVP, Global Corp Affairs | M-Exempt | 11,925 | $1.57M |
| Mon, 20 Jul 2026 | Broadhurst Vanessa | officer: EVP, Global Corp Affairs | M-Exempt | 11,129 | $1.44M |
| Thu, 11 Jun 2026 | Wengel Kathryn E | officer: EVP, Chief TO and Risk Officer | S-Sale | 10,000 | $2.41M |
| Thu, 11 Jun 2026 | Wengel Kathryn E | officer: EVP, Chief TO and Risk Officer | M-Exempt | 10,000 | $1.16M |
| Fri, 1 May 2026 | REED JOHN C | officer: EVP, Innovative Medicine, R&D | M-Exempt | 25,255 | $0 |
| Fri, 1 May 2026 | REED JOHN C | officer: EVP, Innovative Medicine, R&D | F-InKind | 11,002 | $2.53M |
| Fri, 27 Feb 2026 | Decker Robert J | officer: VP Corporate Controller | M-Exempt | 4,075 | $471.36K |
| Fri, 27 Feb 2026 | Decker Robert J | officer: VP Corporate Controller | S-Sale | 4,075 | $1.01M |
| Fri, 20 Feb 2026 | Schmid Timothy | officer: EVP, WW Chair, MedTech | S-Sale | 1,322 | $324.76K |
| Tue, 17 Feb 2026 | Wolk Joseph J | officer: Exec VP, CFO | M-Exempt | 19,241 | $2.23M |
| Tue, 17 Feb 2026 | Wolk Joseph J | officer: Exec VP, CFO | S-Sale | 19,241 | $4.68M |
| Tue, 17 Feb 2026 | Wolk Joseph J | officer: Exec VP, CFO | S-Sale | 24,961 | $6.06M |
| Tue, 17 Feb 2026 | Wolk Joseph J | officer: Exec VP, CFO | M-Exempt | 33,386 | $4.4M |
| Tue, 17 Feb 2026 | Wolk Joseph J | officer: Exec VP, CFO | S-Sale | 12,066 | $2.93M |
| Tue, 17 Feb 2026 | REED JOHN C | officer: EVP, Innovative Medicine, R&D | M-Exempt | 29,927 | $4.67M |
| Tue, 17 Feb 2026 | REED JOHN C | officer: EVP, Innovative Medicine, R&D | S-Sale | 29,927 | $7.27M |
| Tue, 17 Feb 2026 | REED JOHN C | officer: EVP, Innovative Medicine, R&D | S-Sale | 2,283 | $554.77K |
| Tue, 17 Feb 2026 | REED JOHN C | officer: EVP, Innovative Medicine, R&D | S-Sale | 21,721 | $5.28M |
| Tue, 17 Feb 2026 | REED JOHN C | officer: EVP, Innovative Medicine, R&D | M-Exempt | 21,721 | $3.43M |
| Tue, 17 Feb 2026 | Broadhurst Vanessa | officer: EVP, Global Corp Affairs | S-Sale | 6,197 | $1.51M |
| Tue, 17 Feb 2026 | Wolk Joseph J | officer: Exec VP, CFO | S-Sale | 33,386 | $8.1M |
| Wed, 18 Feb 2026 | Schmid Timothy | officer: EVP, WW Chair, MedTech | S-Sale | 8,998 | $2.2M |
| Wed, 18 Feb 2026 | Schmid Timothy | officer: EVP, WW Chair, MedTech | M-Exempt | 8,998 | $1.17M |
| Wed, 18 Feb 2026 | Schmid Timothy | officer: EVP, WW Chair, MedTech | S-Sale | 13,625 | $3.33M |
| Wed, 18 Feb 2026 | Schmid Timothy | officer: EVP, WW Chair, MedTech | M-Exempt | 13,625 | $1.58M |
